awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36768605-B48B2FE1-B0E0-4619-9517-3E4A7E00A180
Q36768605-B48B2FE1-B0E0-4619-9517-3E4A7E00A180
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36768605-B48B2FE1-B0E0-4619-9517-3E4A7E00A180
Alemtuzumab use in relapsed and refractory chronic lymphocytic leukemia: a history and discussion of future rational use
P2860
Q36768605-B48B2FE1-B0E0-4619-9517-3E4A7E00A180
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36768605-B48B2FE1-B0E0-4619-9517-3E4A7E00A180
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f8bafd9987b548374b73d02d2e3c4ac895c32ac8
P2860
Pilot experience with continuous infusion alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia.